Form 4: Pulmonx Corp Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
A Pulmonx Corp executive, Geoffrey Beran Rose, sold a total of 4,378 shares of common stock to cover tax obligations related to vesting Restricted Stock Units.
Summary
- Geoffrey Beran Rose, Chief Commercial Officer of Pulmonx Corp, sold 4,378 shares of common stock on December 2, 2024.
- The sales were executed in multiple transactions at prices of $6.18 and $6.19 per share.
- These sales were made to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- The RSUs were granted on June 1, 2021, March 1, 2022, March 1, 2023, and March 1, 2024.
- Following these transactions, Mr. Rose beneficially owns 291,057 shares of Pulmonx Corp common stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction for tax purposes and does not indicate any positive or negative sentiment towards the company's performance or future prospects.
Industry Context
This is a routine filing related to executive stock transactions and is common for publicly traded companies. It does not indicate any specific trend in the medical device industry.
Comparison to Industry Standards
- Executive stock sales to cover tax obligations are a common practice across publicly traded companies, including those in the medical device sector.
- Similar transactions are regularly reported by executives at companies like Medtronic, Boston Scientific, and Stryker, often following the vesting of stock options or restricted stock units.
- The size of the transaction is relatively small compared to the overall market capitalization of Pulmonx Corp, and is not unusual for a C-level executive.
Stakeholder Impact
- The stock sale is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors due to the relatively small size of the transaction.
Key Dates
| Date | Description |
|---|---|
| 06/01/2021 | Date of grant for some of the Restricted Stock Units (RSUs) that triggered the tax obligations. |
| 03/01/2022 | Date of grant for some of the Restricted Stock Units (RSUs) that triggered the tax obligations. |
| 03/01/2023 | Date of grant for some of the Restricted Stock Units (RSUs) that triggered the tax obligations. |
| 03/01/2024 | Date of grant for some of the Restricted Stock Units (RSUs) that triggered the tax obligations. |
| 12/02/2024 | Date of the stock sales by Geoffrey Beran Rose. |
| 12/04/2024 | Date the Form 4 was signed. |
Keywords
Pulmonx Corp, Geoffrey Beran Rose, stock sale, Form 4, insider trading, Restricted Stock Units, tax obligations, LUNG
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.